Kane Biotech Inc. appointed Audrey Goertzen CPA, CGA as new Chief Financial Officer replacing Mark Matthewson CPA, CA, effective January 4, 2016. Ms. Goertzen has broad experience in financial management and accounting over the past 22 years in public accounting, public and government crown corporations, as well as rapidly growing entrepreneurial companies.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.13 CAD | +4.00% | -13.33% | +62.50% |
1st Jan change | Capi. | |
---|---|---|
+62.50% | 12.03M | |
+49.53% | 56.69B | |
-2.91% | 41B | |
+38.14% | 38.11B | |
-11.22% | 26.89B | |
+15.80% | 25.59B | |
-22.68% | 18.59B | |
-0.10% | 12.39B | |
+27.23% | 11.99B | |
+22.75% | 11.88B |
- Stock Market
- Equities
- KNE Stock
- News Kane Biotech Inc.
- Kane Biotech Inc. Appoints Audrey Goertzen Replacing Mark Matthewson as Chief Financial Officer